mTOR inhibition: a double-edged sword in patients with COVID-19?
Morteza Ghasemnejad‐Berenji
Topics & Concepts
PI3K/AKT/mTOR pathwaySirolimusBiologyMechanistic target of rapamycinSignal transductionAutophagyImmune systemCell biologyImmunologyApoptosisGeneticsBiochemistryPI3K/AKT/mTOR signaling in cancerCytokine Signaling Pathways and InteractionsCRISPR and Genetic Engineering